Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia
Figure 3
Retrospective analysis of the Ma-Spore ALL 2003 cohort according to the presence or absence of the BIM deletion polymorphism.
Kaplan-Meier curves comparing event-free survival (A) or overall survival (B) in patients with or without the BIM deletion polymorphism are shown.